Fredrik Jäderling

1.5k total citations · 1 hit paper
47 papers, 696 citations indexed

About

Fredrik Jäderling is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fredrik Jäderling has authored 47 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fredrik Jäderling's work include Prostate Cancer Diagnosis and Treatment (34 papers), Prostate Cancer Treatment and Research (29 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Fredrik Jäderling is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (34 papers), Prostate Cancer Treatment and Research (29 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Fredrik Jäderling collaborates with scholars based in Sweden, Norway and United Kingdom. Fredrik Jäderling's co-authors include Stefan Carlsson, Tobias Nordström, Martin Eklund, Henrik Grönberg, Markus Aly, Andrea Discacciati, Magnus Annerstedt, Axel Glaessgen, Martin Bergman and Olof Akre and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Fredrik Jäderling

44 papers receiving 690 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

2021 230 citations Martin Eklund, Fredrik Jäderling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fredrik Jäderling Sweden	13	528	177	172	123	111	47	696
André‐Guy Martin Canada	19	774 1.5×	176 1.0×	148 0.9×	67 0.5×	144 1.3×	90	1.0k
Chakiath Jose New Zealand	7	1.1k 2.1×	188 1.1×	144 0.8×	76 0.6×	69 0.6×	9	1.2k
Francesco Barletta Italy	11	488 0.9×	129 0.7×	190 1.1×	164 1.3×	90 0.8×	88	654
Frank‐Jan H. Drost Netherlands	7	809 1.5×	268 1.5×	106 0.6×	287 2.3×	52 0.5×	9	851
Neophytos Petrides United Kingdom	5	379 0.7×	92 0.5×	102 0.6×	92 0.7×	65 0.6×	9	455
Anthony V. D’Amico United States	13	526 1.0×	98 0.6×	77 0.4×	168 1.4×	50 0.5×	22	594
Daniël F. Osses Netherlands	10	979 1.9×	318 1.8×	115 0.7×	356 2.9×	74 0.7×	13	1.0k
Andrea Moore United Kingdom	7	832 1.6×	193 1.1×	93 0.5×	36 0.3×	83 0.7×	11	931
Alice S. Whittemore United States	5	707 1.3×	110 0.6×	188 1.1×	214 1.7×	107 1.0×	5	850
Eric E. K. Yeoh Australia	11	544 1.0×	170 1.0×	163 0.9×	55 0.4×	141 1.3×	13	720

Countries citing papers authored by Fredrik Jäderling

Since Specialization

Citations

This map shows the geographic impact of Fredrik Jäderling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Jäderling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Jäderling more than expected).

Fields of papers citing papers by Fredrik Jäderling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Jäderling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Jäderling. The network helps show where Fredrik Jäderling may publish in the future.

Co-authorship network of co-authors of Fredrik Jäderling

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Jäderling. A scholar is included among the top collaborators of Fredrik Jäderling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Jäderling. Fredrik Jäderling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eklund, Martin, Anna Lantz, Andrea Discacciati, et al.. (2025). Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study. EClinicalMedicine. 82. 103191–103191. 1 indexed citations

Wallström, Jonas, Jan Andersson, Magnus Karlsson, et al.. (2024). An online national quality assessment survey of prostate MRI reading: interreader variability in prostate volume measurement and PI-RADS classification. European Journal of Radiology Open. 14. 100625–100625. 2 indexed citations

Zackrisson, Sophia, et al.. (2024). A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing. Acta Oncologica. 63. 816–821. 2 indexed citations

Nordström, Tobias, Magnus Annerstedt, Axel Glaessgen, et al.. (2024). Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging. JAMA Network Open. 7(2). e2354577–e2354577. 17 indexed citations

Discacciati, Andrea, Mark Clements, Magnus Annerstedt, et al.. (2024). Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging–guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. European Urology Oncology. 8(6). 1466–1473. 2 indexed citations

Discacciati, Andrea, Ugo Giovanni Falagario, Hari T. Vigneswaran, et al.. (2024). Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening. JAMA Network Open. 7(4). e247131–e247131. 9 indexed citations

Lantz, Anna, Ugo Giovanni Falagario, Fredrik Jäderling, et al.. (2023). Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer. European Urology Open Science. 51. 89–94. 1 indexed citations

Rönmark, Erik, Ralf Hoffmann, Fredrik Jäderling, et al.. (2022). Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care. BMJ Health & Care Informatics. 29(1). e100588–e100588. 3 indexed citations

Stranne, Johan, Eva Johansson, Matteo Bottai, et al.. (2022). Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer. European Urology Open Science. 41. 63–73. 7 indexed citations

10.

Hao, Shuang, Emelie Heintz, Ellinor Östensson, et al.. (2022). Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study. European Urology. 82(1). 12–19. 10 indexed citations

11.

Nilsson, Markus, Filip Szczepankiewicz, Mikael Skorpil, et al.. (2021). Mapping prostatic microscopic anisotropy using linear and spherical b‐tensor encoding: A preliminary study. Magnetic Resonance in Medicine. 86(4). 2025–2033. 15 indexed citations

12.

Olsson, Henrik, Tobias Nordström, Fredrik Jäderling, et al.. (2020). Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer. World Journal of Urology. 39(6). 1797–1804. 8 indexed citations

13.

Lantz, Anna, Erik Skaaheim Haug, Wolfgang Picker, et al.. (2020). Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies. World Journal of Urology. 39(4). 1153–1159. 2 indexed citations

14.

Nordström, Tobias, Fredrik Jäderling, Stefan Carlsson, et al.. (2019). Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI. BMJ Open. 9(6). e027816–e027816. 12 indexed citations

15.

Ebbing, Jan, Fredrik Jäderling, Justin Collins, et al.. (2018). Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study. PLoS ONE. 13(6). e0199477–e0199477. 19 indexed citations

16.

Jäderling, Fredrik, Olof Akre, Markus Aly, et al.. (2018). Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery. Prostate Cancer and Prostatic Diseases. 22(3). 391–398. 29 indexed citations

17.

Nordström, Tobias, Wolfgang Picker, Markus Aly, et al.. (2017). Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project. European Urology Focus. 3(6). 526–528. 12 indexed citations

18.

Carlsson, Stefan, Fredrik Jäderling, Anna Wallerstedt, et al.. (2016). Oncological and functional outcomes 1 year after radical prostatectomy for very‐low‐risk prostate cancer: results from the prospective LAPPRO trial. British Journal of Urology. 118(2). 205–212. 29 indexed citations

19.

Jensen, Niels Viggo, et al.. (2016). Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis. Oncology Letters. 12(2). 1293–1300. 13 indexed citations

20.

Båth, Magnus, et al.. (2009). Evaluation of image quality and lesion perception by human readers on 3D CT colonography: comparison of standard and low radiation dose. European Radiology. 20(3). 630–639. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact